Silvadene and Klor-con drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Silvadene (silver sulfadiazine) and Klor-con (potassium chloride). Common drug interactions include confusional state among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Silvadene and Klor-con. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Silvadene?

Silvadene has active ingredients of silver sulfadiazine. eHealthMe is studying from 1,161 Silvadene users. Check the latest studies of Silvadene.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

On Jul, 08, 2026

45 people who take Silvadene and Klor-con together, and have interactions are studied.

Silvadene and Klor-con drug interactions.

What are the common drug interactions of Silvadene and Klor-Con, by gender? *:

female:

Confusional state
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Disease progression
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)
Dry eye (lack of adequate tears)
Abdominal distension

male:

Sepsis (a severe blood infection that can lead to organ failure and death)
Asthenia (weakness)
Dyspnoea (difficult or laboured respiration)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Injury
Renal failure (kidney dysfunction)
Renal failure acute (rapid kidney dysfunction)
Snoring
Ventricular fibrillation (abnormally irregular heart rhythm)

What are the common drug interactions of Silvadene and Klor-Con, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cellulitis (infection under the skin)
Cellulitis gangrenous (localized inflammation of the soft or connective tissue with considerable mass of body tissue dies (necrosis))
Gangrene (body tissue dies)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Perineal abscess
Sepsis (a severe blood infection that can lead to organ failure and death)
Urinary tract infection
Vulval abscess
Vulval cellulitis (inflammation of skin around vagina)
Vulvitis (inflammation of the vulva)

50-59:

Snoring
Thrombocytopenia (decrease of platelets in blood)
Ventricular fibrillation (abnormally irregular heart rhythm)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
Dizziness
Gout (uric acid crystals building up in the body)
Haematuria (presence of blood in urine)
Injury
Renal failure (kidney dysfunction)
Skin lesion

60+:

Fall
Asthenia (weakness)
Diarrhoea
Disease progression
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
Pain in extremity

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 26.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 17.78%
Pain: 7 people, 15.56%
High Blood Pressure: 6 people, 13.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 13.33%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 4 people, 8.89%
Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 8.89%
Weight Decreased: 3 people, 6.67%
Type 2 Diabetes: 3 people, 6.67%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Silvadene and Klor-con?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously